文献速递临床试验与 GCP真实世界研究与卫生经济

评论:西北伦敦临床试验联盟在试验交付中的效率与创新

Commentary: The North West London Clinical Trials Alliance: efficiency and innovation in clinical trial delivery.
PubMed 文献 · Trials · 2024-07-29

本文评述西北伦敦临床试验联盟的组建背景、运行架构与生态系统,旨在通过跨机构战略合作优化临床试验启动与招募。联盟将试验平均启动时间缩短至19天,而西北伦敦商业性试验常规为75天,并在新冠疫情期间于查令十字医院开展的杨森新冠疫苗研究中快速达成招募目标且保持队列多样性。联盟还利用数字技术与基础设施提升对商业资助研究的吸引力。

要点

  • 联盟通过跨医疗与研究机构合作,将临床试验平均启动时间缩短至19天,常规商业性试验为75天。
  • 新冠疫情期间在查令十字医院开展的杨森新冠疫苗研究快速达成招募目标并保持研究队列多样性。
  • 联盟利用数字技术与基础设施提升对商业资助研究的吸引力,展示可持续的试验融资与执行模式。

核心结论

  • 西北伦敦临床试验联盟是对临床试验管理常规挑战的战略性回应,强调跨部门合作与资源优化的价值。
  • 联盟在新冠疫情期间的表现提供了提升试验交付与效率的案例,对区域和全球临床试验研究界具有意义。

研究设计与样本

  • 本文为评论文章,介绍西北伦敦临床试验联盟的组建目的、运行架构及其培育的生态系统。
  • 联盟旨在通过医疗与研究实体间的战略合作,弥合新兴科学研究与临床应用之间的差距。

主要发现

  • 联盟将试验平均启动时间缩短至19天,而西北伦敦商业性试验常规设置通常为75天。
  • 新冠疫情期间,查令十字医院开展的杨森新冠疫苗研究快速达到并超过招募目标,同时保持研究队列多样性。
  • 联盟有效利用数字技术与基础设施,增强了对商业资助研究的吸引力,并展示了临床试验融资与执行的可持续模式。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The set-up, activation, and delivery of clinical trials is pivotal for the advancement of medical science, serving as the primary mechanism through which new therapeutic interventions are validated for clinical use. Despite their critical role, the execution of these trials is often encumbered by a multitude of challenges. The North West London Clinical Trials Alliance (The Alliance) was established to address these complexities. It aims to bridge the gap between emerging scientific research and its clinical application through strategic collaborations among healthcare and research entities, thereby enhancing the regional ecosystem for clinical trials. MAIN TEXT: This commentary aims to offer clarity on the fundamental insights that underlie The Alliance, providing a comprehensive understanding of its operational structure and the ecosystem it has fostered to optimise clinical trial delivery and revenue generation. The strategy employed by The Alliance centres on the cultivation of strategic partnerships across a broad spectrum of stakeholders. This approach addresses key operational challenges in clinical trial management, facilitating improvements in the development, setup, activation, and recruitment stages. Notably, The Alliance has reduced the average time to initiate trials to 19 days, compared to the standard 75 days typically observed for commercial setups in North West London. The effectiveness of The Alliance's framework was notably demonstrated during the COVID-19 pandemic, particularly with the expedited recruitment performance in the Janssen COVID-19 vaccine study conducted at Charing Cross Hospital. This instance highlighted the Alliance's capability to meet and exceed recruitment targets promptly while maintaining diversity within study cohorts. Additionally, The Alliance has effectively harnessed digital technology and infrastructure, enhancing its attractiveness to commercially funded studies and illustrating a sustainable model for clinical trial financing and execution. CONCLUSION: The North West London Clinical Trials Alliance represents a strategic response to the conventional challenges faced in clinical trial management, emphasising the importance of cross-sectoral collaboration and resource optimisation. Its efforts, particularly highlighted by its response to the COVID-19 pandemic, provide a case study in enhancing trial delivery and efficiency with significant implications for both regional and global clinical trials research communities.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kierkegaard P, Su B, Wong R, et al. Commentary: The North West London Clinical Trials Alliance: efficiency and innovation in clinical trial delivery. Trials. 2024. PMID: 39069627. doi:10.1186/s13063-024-08344-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。